Saturday, January 19, 2013

• The Good, The Bad, and The Ugly with The Medicines Companyat Motley Fool (Sat, Jan 19)

Friday, January 18, 2013

• Will the Feuerstein-Ratain Rule Hold in 2013?at Motley Fool (Fri, Jan 18)
• Biotech Stock Mailbag: Peregrine, Arena, Dendreon, NPS Pharmaat TheStreet (Fri, Jan 18)

Thursday, January 17, 2013

• 2 Speculative Stocks Soaring in 2013at Motley Fool (Thu, Jan 17)

Wednesday, January 16, 2013

• Alnylam Prices Public OfferingZacks (Wed, Jan 16)

Tuesday, January 15, 2013

• Alnylam to Raise $125 MillionZacks (Tue, Jan 15)

Monday, January 14, 2013

• This Week in Biotechat Motley Fool (Mon, Jan 14)

Thursday, January 10, 2013

• Geron's Update on Stem Cell AssetsZacks (Thu, Jan 10)

Wednesday, January 9, 2013

• Down 10%: Peregrine Hits the Brakesat Motley Fool (Wed, Jan 9)
• Peregrine Recovers As Phase II Trial Is Salvagedat Seeking Alpha (Wed, Jan 9)
• 4 Biotechnology Stocks With Upcoming Catalystsat Seeking Alpha (Wed, Jan 9)
• REGN Predicts Eylea Growth in 2013Zacks (Wed, Jan 9)

Tuesday, January 8, 2013

• Where Will the Data Roller Coaster End?at Motley Fool (Tue, Jan 8)
• Monday’s Most Significant Movers & the Meaning to Such Movementat Motley Fool (Tue, Jan 8)
• Now You See It, Now You Don't: Peregrine's Bavi Might Work After Allat Seeking Alpha (Tue, Jan 8)
• Tuesday's Small Cap Biopharma Investment And Catalyst Trade Listat Seeking Alpha (Tue, Jan 8)
• Today's Market News To Trade On: 5 Stocks Moving On Newsat Seeking Alpha (Tue, Jan 8)

Monday, January 7, 2013

• PEREGRINE PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Mon, Jan 7)
• Peregrine shares rise on cancer study reviewAP (Mon, Jan 7)
• The Nasdaq Now: Apple, Amazon Move in Opposite Directions After Analyst Actionat Minyanville (Mon, Jan 7)
• Up 70%, Peregrine's Clinical Lemon Becomes Lemonadeat Motley Fool (Mon, Jan 7)
• Peregrine Pharmaceutical's Big Jumpat Seeking Alpha (Mon, Jan 7)
• Peregrine provides update on the internal review of its Phase II NSCLC trialat theflyonthewall.com (Mon, Jan 7)
• Peregrine Pharmaceuticals Provides Update on the Internal Review of Its Phase II Second-Line Non-Small Cell Lung Cancer TrialMarketwired (Mon, Jan 7)

Friday, January 4, 2013

• 5 Stocks Poised for Breakoutsat TheStreet (Fri, Jan 4)

Add PPHM News to My Yahoo!